tm logo
CYTOKINETICS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 31 Jul 2024

Last Applicant/ Owned by

350 Oyster Point Blvd

South San Francisco

CA

94080

Serial Number

86264078 filed on 28th Apr 2014

Registration Number

5380852 registered on 16th Jan 2018

in the Principal Register

Correspondent Address

B. Brett Heavner

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CYTOKINETICS

Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]


First Use Date in General

01st Jun 2009

First Use Date in Commerce

01st Jun 2009

Mark Details


Serial Number

No 86264078

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 09367.0198

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31st Jul 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th Jan 2024TEAS SECTION 8 & 15 RECEIVED
16th Jan 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16th Jan 2018REGISTERED-PRINCIPAL REGISTER
13th Dec 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12th Dec 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30th Nov 2017STATEMENT OF USE PROCESSING COMPLETE
27th Nov 2017USE AMENDMENT FILED